| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/12/2000 | EP0991721A2 Use of polycarbonates containing iodine phenyl carbonate for producing special shaped parts |
| 04/12/2000 | EP0991430A1 Compositions and methods for x-ray imaging of tumors |
| 04/12/2000 | EP0991429A1 Use of acousto-optical and sonoluminescence contrast agents |
| 04/12/2000 | EP0991428A4 Delta1,2 bicyclo 4,4,0] functional dyes for contrast enhancement in optical imaging |
| 04/12/2000 | EP0991428A1 Delta1,2 bicyclo 4,4,0] functional dyes for contrast enhancement in optical imaging |
| 04/12/2000 | EP0991427A2 Improvements in or relating to diagnostic/therapeutic agents |
| 04/12/2000 | EP0991356A1 Device for projection mammography |
| 04/12/2000 | EP0620744B1 Improvements in or relating to contrast agents |
| 04/11/2000 | US6048980 Process of preparing tetraaza tetraacetic acid |
| 04/11/2000 | US6048979 Cyclotetramerizing, cleavage of arylmethyl groups to prepare cyclen and derivatives |
| 04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
| 04/11/2000 | US6048537 Concentration, purification, fragmentation, deactivation |
| 04/11/2000 | US6048515 Iron-containing nanoparticles with double coating and their use in diagnosis and therapy |
| 04/11/2000 | US6048514 Amylin activity assays |
| 04/06/2000 | WO2000018949A2 Delivery of phosphoinositide polyphosphates into cells |
| 04/06/2000 | WO1999067284A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 04/06/2000 | WO1999060920A3 Mr signal-emitting coatings |
| 04/06/2000 | WO1999058162A3 Pharmaceuticals for the imaging of angiogenic disorders |
| 04/06/2000 | WO1999052858A3 Lipids |
| 04/06/2000 | CA2345532A1 Delivery of phosphoinositide polyphosphates into cells |
| 04/05/2000 | EP0990258A1 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/05/2000 | EP0990257A1 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/05/2000 | EP0990256A1 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/05/2000 | EP0990168A1 Overhauser magnetic resonance imaging (ormi) method comprising ex vivo polarization of a magnetic resonance (mr) imaging agent |
| 04/05/2000 | EP0989847A1 Anti-tumoral therapy agent |
| 04/05/2000 | EP0871608B1 Monofunctionalised EDTA-, DTPA- and TTHA-Derivatives and their use for the preparation of a diagnoctic or therapeutic medicine |
| 04/05/2000 | EP0733072B1 Antibody against carcinoembryonic antigen (cea) |
| 04/05/2000 | EP0605477B1 Gaseous ultrasound contrast media |
| 04/05/2000 | CN1249692A X-ray contrast media |
| 04/05/2000 | CN1051096C Oligomers, their uses and formulations |
| 04/04/2000 | US6045821 Chelate compound immobilized on membrane whereby the chelating agent comprises a macrocyclic chelant moiety with a lipophilic membrane associating moiety attached to ring atom; organometallic compound medical diagnostic agents |
| 04/04/2000 | US6045777 Determining range of wall thicknesses of microparticles resulting in highest amounts of total returned power as a function of material forming microparticles and gas to be encapsulated, producing suitable microparticles; ultrasound |
| 04/04/2000 | US6045776 Mixture of metal-complex carboxylic acid and at least one solubilizing substance in dimethyl sulfoxide is pretreated with a dehydrating reagent, optionally with the addition of a coupling adjuvant, and is then reacted with an amine |
| 04/04/2000 | US6045775 Parenteral administration of positive and negative contrast agents for MRI |
| 04/04/2000 | US6045773 Method of detecting cyclooxygenase-2 |
| 04/04/2000 | CA2031129C Chimeric antibody for detection and therapy of infectious and inflammatory lesions |
| 03/30/2000 | WO2000017360A1 Cystine knot growth factor mutants |
| 03/30/2000 | WO2000016811A2 Mri contrast agent |
| 03/30/2000 | WO2000016810A1 Near infrared fluorescent contrast agent and fluorescence imaging |
| 03/30/2000 | WO2000016805A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/30/2000 | WO2000002584A3 Cancer treatment methods using antibodies to aminophospholipids |
| 03/30/2000 | CA2413033A1 Near infrared fluorescent contrast agent and fluorescence imaging |
| 03/30/2000 | CA2344315A1 Near infrared fluorescent contrast agent and fluorescence imaging |
| 03/30/2000 | CA2344277A1 Cystine knot growth factor mutants |
| 03/30/2000 | CA2343918A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 03/29/2000 | EP0989184A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding |
| 03/29/2000 | EP0989137A2 Diagnostic agents for pancreatic exocrine function |
| 03/29/2000 | EP0988864A1 Contrast agent for magnetic resonance tomography |
| 03/29/2000 | EP0988062A1 Selectively binding ultrasound contrast agents |
| 03/29/2000 | EP0988061A1 Methods for delivering bioactive agents |
| 03/29/2000 | EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 03/29/2000 | EP0946203A4 Tricyclic functional dyes for contrast enhancement in optical imaging |
| 03/29/2000 | EP0702525A4 Magnetic resonance imaging agent comprising barium sulfate and a clay |
| 03/29/2000 | EP0677171B1 Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders |
| 03/29/2000 | CN1050836C Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates preparation process |
| 03/28/2000 | US6042809 Administrable compositions and methods for magnetic resonance imaging |
| 03/28/2000 | CA2166459C Methods for making encapsulated microspheres from heat denatured protein |
| 03/23/2000 | WO2000016099A1 Recombinant reduced valency carbohydrate binding ligands |
| 03/23/2000 | WO2000015267A1 Contrast agent |
| 03/23/2000 | WO2000015266A2 Radio-contrast agents |
| 03/23/2000 | WO2000015231A1 Adenosine a3 receptor modulators |
| 03/23/2000 | WO1999062512A9 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical substances containing the same, method for the production and use thereof in photodynamic therapy and mri diagnosis |
| 03/23/2000 | CA2348020A1 Radio-contrast agents |
| 03/22/2000 | EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same |
| 03/22/2000 | EP0986340A1 Radiopaque solution for visualizing dental anatomy, pathological conditions, and iatrogenic events, and method of use |
| 03/22/2000 | EP0986309A1 Uses of oil bodies |
| 03/22/2000 | EP0861259A4 Process for producing tungsten clusters |
| 03/22/2000 | EP0860170B1 Tablets based on isotope-labeled urea |
| 03/22/2000 | EP0812151B1 Method for magnetic resonance imaging of arteries using a magnetic resonance contrast agent |
| 03/22/2000 | EP0772776B1 Superparamagnetic particles, process for their production and their use |
| 03/22/2000 | CN1248177A Coated particles, method of making and using |
| 03/22/2000 | CN1050668C Method for early detection of septicaemia and for treatment-accompanying assessment of course of sepsis, as well as means for carrying out said method |
| 03/21/2000 | US6040432 Metal complexes, of DTPA derivatives suitable for use in diagnosis and therapy |
| 03/21/2000 | US6040194 Methods and device for detecting and quantifying substances in body fluids |
| 03/21/2000 | US6040147 Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 03/21/2000 | US6039931 Complexes and drugs for nmr images and medical diagnosis |
| 03/21/2000 | US6039557 Apparatus for making gas-filled vesicles of optimal size |
| 03/16/2000 | WO2000014547A1 Immunodiagnostics using particle delivery methods |
| 03/16/2000 | WO2000014236A2 Grf analogs with increased biological potency |
| 03/16/2000 | WO2000013713A1 Macroscopic sweat test for cystic fibrosis |
| 03/16/2000 | WO2000013590A2 System and method for radiographic imaging of tissue |
| 03/16/2000 | WO2000013509A1 Method of determining and reducing the risk of bph-related urologic events |
| 03/16/2000 | WO1999060131A3 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/16/2000 | WO1999058570A3 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/16/2000 | WO1999057151A3 FAP α-SPECIFIC ANTIBODY WITH IMPROVED PRODUCIBILITY |
| 03/16/2000 | CA2342832A1 Immunodiagnostics using particle delivery methods |
| 03/16/2000 | CA2342070A1 Grf analogs with increased biological potency |
| 03/15/2000 | EP0985028A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 03/15/2000 | EP0767621A4 Implantable capsule for enhancing cell electric signals |
| 03/15/2000 | EP0760684A4 Gas filled microspheres as computed tomography contrast agents |
| 03/14/2000 | US6037494 Crystallizing pure iopamidol from the alcohol solvents which give azeotropes with water forming two separate layers; lower has minimal removable solvent content, and upper layer can be recycled to reduce amount of solvent used |
| 03/14/2000 | US6037467 Methods for preparing carbohydrate-containing hydrophilic polymers |
| 03/14/2000 | US6037134 Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes |
| 03/14/2000 | US6036955 Antitumor agents |
| 03/14/2000 | US6036941 Fluorogenic substrates for diagnosis and photodynamic treatment of tumors |
| 03/14/2000 | US6036644 Enhanced methods of ultrasound imaging using multiple frequencies |
| 03/14/2000 | CA2045543C Iodinated esters |
| 03/14/2000 | CA2010177C Purified mite allergen |
| 03/09/2000 | WO2000012758A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 03/09/2000 | WO2000012536A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |